Your browser is no longer supported. Please, upgrade your browser.
Settings
HRTX Heron Therapeutics, Inc. daily Stock Chart
HRTX [NASD]
Heron Therapeutics, Inc.
Index- P/E- EPS (ttm)-2.92 Insider Own0.10% Shs Outstand74.01M Perf Week1.47%
Market Cap2.04B Forward P/E- EPS next Y-1.06 Insider Trans-97.33% Shs Float74.01M Perf Month1.28%
Income-191.80M PEG- EPS next Q-0.46 Inst Own- Short Float18.62% Perf Quarter1.69%
Sales58.70M P/S34.82 EPS this Y20.00% Inst Trans4.10% Short Ratio16.05 Perf Half Y-28.26%
Book/sh5.23 P/B5.28 EPS next Y53.70% ROA-54.80% Target Price51.83 Perf Year19.05%
Cash/sh4.93 P/C5.60 EPS next 5Y29.40% ROE-72.20% 52W Range20.05 - 42.90 Perf YTD6.48%
Dividend- P/FCF- EPS past 5Y-12.80% ROI-121.80% 52W High-35.62% Beta1.58
Dividend %- Quick Ratio6.70 Sales past 5Y- Gross Margin70.60% 52W Low37.76% ATR1.07
Employees145 Current Ratio7.20 Sales Q/Q130.20% Oper. Margin- RSI (14)56.36 Volatility4.14% 3.97%
OptionableYes Debt/Eq0.01 EPS Q/Q36.20% Profit Margin- Rel Volume1.27 Prev Close26.20
ShortableYes LT Debt/Eq0.00 EarningsFeb 26 AMC Payout- Avg Volume858.49K Price27.62
Recom1.60 SMA203.09% SMA505.85% SMA200-12.60% Volume1,088,917 Change5.42%
Jan-16-19Reiterated Needham Buy $66 → $64
Apr-05-18Initiated Evercore ISI Outperform $56
Mar-19-18Reiterated Mizuho Buy $28 → $35
Mar-01-18Reiterated Needham Buy $28 → $30
Jan-03-18Initiated Leerink Partners Outperform $22
Sep-27-17Initiated Northland Capital Outperform $40
Feb-27-17Initiated Needham Buy $28
Oct-26-16Initiated Aegis Capital Buy
Sep-06-16Resumed Lake Street Buy $45
May-03-16Initiated Cantor Fitzgerald Buy
Dec-10-15Initiated Lake Street Buy $45
Sep-23-15Reiterated Leerink Partners Outperform $38 → $57
Sep-02-15Initiated BofA/Merrill Buy $46
Aug-03-15Reiterated Brean Capital Buy $40 → $45
Jun-30-15Reiterated JMP Securities Mkt Outperform $25 → $33
Jun-19-15Reiterated Leerink Partners Outperform $26 → $38
Aug-07-14Initiated Noble Financial Buy $18
Feb-06-19 02:58PM  How Much Did Heron Therapeutics, Inc.s (NASDAQ:HRTX) CEO Pocket Last Year? Simply Wall St.
Feb-05-19 04:30PM  Heron Therapeutics Announces Retirement of Robert Rosen as President PR Newswire
Jan-31-19 07:50AM  Today's Research Reports on Trending Tickers: Mylan and Heron Therapeutics ACCESSWIRE
Jan-30-19 07:35AM  New Research Coverage Highlights Heron Therapeutics, IDACORP, Star Bulk Carriers, AngioDynamics, Marinus Pharmaceuticals, and Advaxis Consolidated Revenues, Company Growth, and Expectations for 2019 GlobeNewswire
Jan-07-19 08:30AM  Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises PR Newswire
Jan-03-19 08:30AM  90% of Patients Remain Opioid-Free When HTX-011 Is Given with an Over-the-Counter Analgesic Regimen in New Multi-center Postoperative Pain Management Study PR Newswire
Jan-02-19 09:30AM  Company News For Jan 2, 2019 Zacks
06:58AM  Heron Gains on Priority Review Designation for Pain Drug Zacks
Dec-31-18 04:05PM  Heron Therapeutics to Present at the 37th Annual J.P. Morgan Healthcare Conference PR Newswire +9.22%
08:52AM  Heron stock up 4.3% after opioid alternative granted priority review designation from FDA MarketWatch
08:30AM  FDA Grants Priority Review Designation for Heron Therapeutics' NDA for HTX-011, a Non-Opioid for Postoperative Pain Management PR Newswire
Dec-09-18 03:06AM  Hedge Funds Are Buying Heron Therapeutics Inc (HRTX) Insider Monkey
Nov-29-18 06:55AM  Today's Research Reports on Trending Tickers: Heron Therapeutics and Supernus Pharmaceuticals ACCESSWIRE
Nov-27-18 07:50AM  Report: Exploring Fundamental Drivers Behind Aclaris Therapeutics, Extreme Networks, Care, Air Lease, Globus Medical, and Heron Therapeutics New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Nov-26-18 07:00AM  Today's Research Reports on Trending Tickers: Cronos Group and Heron Therapeutics ACCESSWIRE
Nov-21-18 10:16AM  When Will Heron Therapeutics Inc (NASDAQ:HRTX) Become Profitable? Simply Wall St. +6.01%
Nov-20-18 04:05PM  Heron Therapeutics to Present at the Evercore ISI HealthCONx Conference PR Newswire
Nov-12-18 04:01PM  U.S. Surgeon General Jerome Adams Discusses Opioid Alternatives and the Importance of Partnerships at Heron Therapeutics PR Newswire
07:05AM  Today's Research Reports on Trending Tickers: Heron Therapeutics and Bristol-Myers Squibb ACCESSWIRE
Nov-07-18 07:05PM  Heron Therapeutics (HRTX) Reports Q3 Loss, Tops Revenue Estimates Zacks +7.68%
06:02PM  Heron Therapeutics: 3Q Earnings Snapshot Associated Press
04:05PM  Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2018 and Recent Corporate Progress PR Newswire
Oct-31-18 04:01PM  Heron Announces FDA Submission of HTX-011 NDA for Postoperative Pain Management PR Newswire
Oct-23-18 06:58PM  Cramer's lightning round: If you want to invest in non-op... CNBC Videos
Oct-12-18 07:40AM  Factors of Influence in 2018, Key Indicators and Opportunity within Cloud Peak Energy, Ralph Lauren, CytomX Therapeutics, Extreme Networks, Heron Therapeutics, and Alteryx New Research Emphasizes Economic Growth GlobeNewswire
Oct-09-18 02:07PM  Why Heron Therapeutics Inc (NASDAQ:HRTX) Is A Financially Healthy Company Simply Wall St.
Sep-26-18 08:00AM  Today's Research Reports on Trending Tickers: AVEO Pharmaceuticals and Heron Therapeutics ACCESSWIRE -8.26%
Sep-24-18 04:05PM  Heron Therapeutics to Present at the 2018 Cantor Global Healthcare Conference PR Newswire
Sep-14-18 08:30AM  Implied Volatility Surging for Heron Therapeutics (HRTX) Stock Options Zacks
Aug-13-18 08:00AM  New Research Coverage Highlights East West, Heron Therapeutics, Invacare, CNO Financial Group, Fortinet, and Realogy Consolidated Revenues, Company Growth, and Expectations for 2018 GlobeNewswire
Aug-09-18 06:32AM  2 Growth Stocks That Could Make You Rich Motley Fool
Aug-08-18 10:00AM  Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates Zacks
08:55AM  Heron Therapeutics: 2Q Earnings Snapshot Associated Press
08:30AM  Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2018 and Recent Corporate Progress PR Newswire
Aug-01-18 08:00AM  Today's Research Reports on Trending Tickers: Heron Therapeutics and Pfizer ACCESSWIRE
Jul-26-18 12:31PM  Why Pacira Pharmaceuticals Stock Is on the Rise Today Motley Fool
Jul-06-18 07:55AM  Free Pre-Market Technical Recap on Sanofi and Three Additional Drug Makers Stocks ACCESSWIRE
Jun-28-18 08:00AM  Today's Research Reports on Trending Tickers: Heron Therapeutics and Array BioPharma ACCESSWIRE
Jun-27-18 08:11AM  Is There An Opportunity With Heron Therapeutics Incs (NASDAQ:HRTX) 33.58% Undervaluation? Simply Wall St.
Jun-25-18 10:01PM  Heron Therapeutics Announces Pricing of Public Offering of Common Stock Business Wire
04:01PM  Heron Therapeutics Announces Public Offering of Common Stock Business Wire
Jun-23-18 07:15AM  3 Biotech Stocks That Soared This Week: Are They Buys? Motley Fool
Jun-22-18 08:51AM  Benzinga's Daily Biotech Pulse: FDA Greenlights Tandem Diabetes' Insulin Pump, More IPOs On Tap Benzinga
08:10AM  Todays Research Reports on Stocks to Watch: Heron Therapeutics and Stellar Biotechnologies ACCESSWIRE
06:52AM  Heron Therapeutics stock rockets 30% on high hopes for post-surgery pain treatment MarketWatch
Jun-21-18 04:33PM  Why Stitch Fix, Barnes & Noble Education, and Heron Therapeutics Jumped Today Motley Fool +30.13%
02:04PM  Why Heron Therapeutics Stock Is Blasting Higher Today Motley Fool
11:19AM  Drugs from Heron Therapeutics and two other biotech companies can boost your investment returns by reducing opioid abuse MarketWatch
08:17AM  Heron Therapeutics shares surge 33% after positive FDA response to pain treatment MarketWatch
08:05AM  HTX-011 for Postoperative Pain Management Receives Breakthrough Therapy Designation from FDA Business Wire
08:00AM  Heron Announces Positive Topline Results from Phase 2b Clinical Studies of HTX-011 in Total Knee Arthroplasty and Breast Augmentation Business Wire
Jun-01-18 07:30AM  Breakfast Technical Briefing on Johnson & Johnson and Three Other Additional Healthcare Stocks ACCESSWIRE
May-29-18 04:05PM  Heron Therapeutics to Present at the Jefferies 2018 Healthcare Conference Business Wire
May-23-18 09:07AM  3 Stocks the World's Best Investors Are Buying Right Now Motley Fool
May-14-18 08:10AM  Analysis: Positioning to Benefit within Advaxis, e.l.f. Beauty, Heron Therapeutics, PVH, Energy Recovery, and A. O. Smith Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +5.53%
May-10-18 08:52AM  Heron Therapeutics: 1Q Earnings Snapshot Associated Press
08:30AM  Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2018 and Recent Corporate Progress Business Wire
May-09-18 04:05PM  Heron Therapeutics to Present at the Bank of America Merrill Lynch 2018 Healthcare Conference Business Wire
May-02-18 12:01PM  Harry Boxers four biotech stocks to watch today MarketWatch
May-01-18 09:32PM  Don't Waste Your Money On Penny Stocks -- These 3 Stocks Are Better Buys Motley Fool
Apr-26-18 11:19AM  Harry Boxers two biotechnology stocks to watch today MarketWatch
Apr-11-18 07:43PM  An Intrinsic Calculation For Heron Therapeutics Inc (NASDAQ:HRTX) Shows Its 36% Undervalued Simply Wall St.
Mar-28-18 08:53PM  Heron Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock Business Wire
04:14PM  Heron Therapeutics Announces Proposed Public Offering of Common Stock Business Wire
Mar-26-18 06:41AM  The Zacks Analyst Blog Highlights: AbbVie, J&J, Heron Therapeutics, Roche and Pfizer Zacks
Mar-24-18 09:32AM  3 Biotech Stocks That Skyrocketed This Week: Are They Buys? Motley Fool
Mar-23-18 04:22PM  Pharma Stock Roundup: ABBV's Rova-T Disappoints, J&J Unit Gets Buyout Offer Zacks
Mar-21-18 04:05PM  Heron Therapeutics to Present at the 17th Annual Needham Healthcare Conference Business Wire
Mar-20-18 11:49AM  Heron's Pain Candidate Meets Endpoint in Pivotal Studies Zacks
Mar-19-18 05:47PM  Why Heron Therapeutics Stock Soared Today Motley Fool +26.98%
05:26PM  This Biotech Stock Catapulted After Its Pain Drug Trumped A Key Rival Investor's Business Daily
05:03PM  What Happened in the Stock Market Today Motley Fool
08:33AM  UPDATE: Heron Therapeutics stock jumps 28% on news of positive results for anesthetic agent MarketWatch
08:20AM  Heron Therapeutics stock jumps 18.6% on news of positive results for anesthetic agent MarketWatch
08:00AM  Heron Announces Positive Topline Results From Pivotal Phase 3 Clinical Trials of HTX-011 in Bunionectomy and Hernia Repair Business Wire
Mar-06-18 04:05PM  Heron Therapeutics to Present at the 38th Annual Cowen Healthcare Conference Business Wire
Feb-28-18 05:04AM  Heron Therapeutics reports 4Q loss Associated Press -7.71%
Feb-27-18 04:15PM  Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2017 and Recent Corporate Progress Business Wire
Feb-12-18 04:05PM  Heron Therapeutics to Present at the 7th Annual Leerink Partners Global Healthcare Conference Business Wire
Feb-09-18 07:45AM  Research Report Identifies Hill-Rom, Quantum, Heron Therapeutics, Dillard's, LightPath Technologies, and Adesto Technologies with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Jan-22-18 08:47AM  Options Traders Expect Huge Moves in Heron Therapeutics (HRTX) Stock Zacks
Jan-11-18 03:00AM  Heron Therapeutics Joins Elite Club Of Stocks With RS Ratings Over 90 Investor's Business Daily +6.39%
Jan-08-18 08:30AM  Heron Therapeutics Highlights Progress in CINV and Pain Management Franchises Business Wire
Jan-02-18 04:05PM  Heron Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference Business Wire
06:39AM  Want To Invest In Heron Therapeutics Inc (NASDAQ:HRTX)? Heres How It Performed Lately Simply Wall St.
Dec-20-17 07:22AM  Heron Therapeutics, Inc. is trading above its 50 day moving average : HRTX-US : December 20, 2017 Capital Cube
03:00AM  Heron Therapeutics Earns Relative Strength Rating Upgrade; Hits Key Benchmark Investor's Business Daily
Dec-14-17 02:49PM  10 Strong Buy Stocks That Are Better Than Bitcoin InvestorPlace
Dec-06-17 07:44AM  Heron Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : HRTX-US : December 6, 2017 Capital Cube
Dec-05-17 05:04PM  Why Heron Therapeutics Stock Is Crashing Today Motley Fool -9.62%
09:00AM  Heron Therapeutics Announces Pricing of Public Offering of Common Stock Business Wire
Dec-04-17 04:01PM  Heron Therapeutics Announces Public Offering of Common Stock Business Wire
Dec-01-17 03:00AM  Heron Therapeutics Trying To Close In On Key Technical Benchmark Investor's Business Daily
Nov-21-17 03:49PM  What does Heron Therapeutics Incs (HRTX) Balance Sheet Tell Us Abouts Its Future? Simply Wall St.
Nov-20-17 08:10AM  Recent Analysis Shows Premier, Quantum, Heron Therapeutics, Dillard's, LightPath Technologies, and Ichor Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire
Nov-17-17 07:25AM  Heron Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : HRTX-US : November 17, 2017 Capital Cube
Nov-12-17 12:00PM  5 Small Biotechs Receive Shots in the Arm TheStreet.com
Nov-09-17 04:05PM  Heron Therapeutics Announces U.S. FDA Approval of CINVANTI (aprepitant) Injectable Emulsion for the Prevention of Acute and Delayed Chemotherapy-Induced Nausea and Vomiting (CINV) Business Wire
Nov-08-17 04:05PM  Heron Therapeutics to Present at the Jefferies London Healthcare Conference Business Wire +5.62%
Nov-07-17 11:14AM  Heron Therapeutics, Inc. Value Analysis (NASDAQ:HRTX) : November 7, 2017 Capital Cube
Heron Therapeutics, Inc., a biotechnology company, engages in developing medicines to address unmet medical needs. The company's product candidates utilize its proprietary Biochronomer drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration. It offers SUSTOL (granisetron) extended-release injection for the prevention of acute and delayed chemotherapy-induced nausea and vomiting (CINV) associated with moderately emetogenic chemotherapy, or anthracycline and cyclophosphamide combination chemotherapy regimens. The company is also developing CINVANTI, a neurokinin-1 receptor antagonist aprepitant for the prevention of CINV; and HTX-011, which is in Phase III clinical development for the prevention of post-operative pain. The company was formerly known as A.P. Pharma, Inc. and changed its name to Heron Therapeutics, Inc. in January 2014. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MANHARD KIMBERLYExecutive VP, Drug DevelopmentNov 02Sale30.6249415,1250Nov 02 09:17 PM
MANHARD KIMBERLYExecutive VP, Drug DevelopmentOct 01Option Exercise13.006,00078,0006,000Oct 02 09:12 PM
MANHARD KIMBERLYExecutive VP, Drug DevelopmentOct 01Sale32.076,000192,4330Oct 02 09:12 PM
Quart Barry DChief Executive OfficerSep 14Option Exercise7.2019,675141,66089,275Sep 14 11:41 AM
TANG KEVIN CDirectorSep 12Sale35.752,695,00096,346,2505,830,215Sep 12 12:28 PM
Rosen RobertPresidentJul 02Option Exercise7.2095,531687,82398,171Jul 03 09:01 PM
HOFFMAN ROBERTCFO & SVP, FinanceJul 02Option Exercise15.3030,000459,00031,280Jul 03 09:03 PM
MANHARD KIMBERLYExecutive VP, Drug DevelopmentJul 02Option Exercise13.006,00078,0006,000Jul 03 09:05 PM
HOFFMAN ROBERTCFO & SVP, FinanceJul 02Sale38.1730,0001,145,2301,280Jul 03 09:03 PM
MANHARD KIMBERLYExecutive VP, Drug DevelopmentJul 02Sale37.536,000225,1790Jul 03 09:05 PM
Rosen RobertPresidentJul 02Sale38.1595,5313,644,6832,640Jul 03 09:01 PM
Rosen RobertPresidentJun 29Option Exercise7.20129,469932,177132,109Jul 03 09:01 PM
Rosen RobertPresidentJun 29Sale39.59129,4695,125,1352,640Jul 03 09:01 PM
Quart Barry DChief Executive OfficerJun 21Option Exercise9.0550,000452,500119,600Jun 22 09:35 PM
Quart Barry DChief Executive OfficerJun 21Sale39.0550,0001,952,50069,600Jun 22 09:35 PM
TANG KEVIN CDirectorMar 29Buy26.00192,3085,000,0088,525,215Apr 02 04:01 PM
Quart Barry DChief Executive OfficerMar 19Option Exercise7.20100,000720,000167,993Mar 19 07:22 PM
MANHARD KIMBERLYExecutive VP, Drug DevelopmentMar 19Option Exercise13.0018,000234,00018,000Mar 19 07:24 PM
MANHARD KIMBERLYExecutive VP, Drug DevelopmentMar 19Sale30.0018,000540,0000Mar 19 07:24 PM
Quart Barry DChief Executive OfficerMar 19Sale29.75100,0002,975,00067,993Mar 19 07:22 PM
Quart Barry DChief Executive OfficerMar 14Option Exercise7.20100,000720,000167,993Mar 16 09:00 PM
Quart Barry DChief Executive OfficerMar 14Sale24.75100,0002,475,00067,993Mar 16 09:00 PM